Document

30day notice

ICR 202609-0925-001 · OMB 0925-0698 · Object 174228200.

Document Viewer [pdf]

Status: Original and derived artifacts are available for this document.

Download: pdf

Primary: pdfSource: application/pdf
Loading document viewer…

Document Metadata

Record metadata
application/pdf
30day notice
govinfo, U. S. Government Publishing Office
2026-10-27
2026-10-27
complete

Extracted Text

67592

Federal Register / Vol. 91, No. 206 / Tuesday, October 27, 2026 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued

Form
No.

Form name

5 ........

OPTN Ad hoc Conflict-of-Interest Disclosure Questionnaire ** +.
OPTN Attestation Form ......................................................
OPTN Code of Conduct Form ...........................................
OPTN Volunteer Confidentiality Agreement + ....................
Total ............................................................................

6 ........
7 ........
8 ........

Number of
respondents

Number of
responses per
respondent

Total
responses

Average
burden per
response
(in hours)

74

24

1,776

0.08

142.08

505
1,346
1,346

1
1
1

505
1,346
1,346

0.08
0.08
0.08

40.40
107.68
107.68

5,833

........................

7,683

....................

2,110.84

Total
burden
hours

* Estimated responses per year, every 2-to-3 years.
** Board members submit ad hoc conflict-of-interest forms prior to each monthly meeting, and before any ad hoc Board Meeting or Executive
Board meeting with specific institution-based discussion.
+ Form name has been updated since the publication of the 60-day Federal Register Notice.
Amy P. McNulty,
Deputy Director, Executive Secretariat.
[FR Doc. 2026–21857 Filed 10–26–26; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings

lotter on DSK8BHNXB4PROD with NOTICES1

Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurosensory Systems.
Date: November 23–24, 2026.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
ADDRESS: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Li Jia, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 594–8068,
[email protected].
Name of Committee: Center for Scientific
Review, Special Emphasis Panel; RFA Panel:
Cardiovascular Science.
Date: November 23, 2026.
Time: 9:30 a.m. to 1:00 p.m.

VerDate Sep<11>2014

17:59 Oct 26, 2026

Jkt 271001

Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Nawazish Ali Naqvi,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 827–7911, nawazish.naqvi@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cognitive
and Language Habilitation and
Rehabilitation.
Date: November 23–24, 2026.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Devon Rene Oskvig, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–9088, devon.oskvig@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Training
and Career Development: Epidemiology and
Population Health.
Date: November 24, 2026.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Magnus A. Azuine, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–7579, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Interdisciplinary fields of
Bioengineering, Imaging and Vascular
Sciences.
Date: November 24, 2026.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.

PO 00000

Frm 00053

Fmt 4703

Sfmt 4703

Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 827–7085, zhihong.shan@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 23, 2026.
Margaret N. Vardanian,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2026–21903 Filed 10–26–26; 8:45 am]
BILLING CODE 4167–05–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; The Impact of
Clinical Research Training and Medical
Education at the Clinical Center on
Physician Careers in Academia and
Clinical Research
AGENCY: National Institutes of Health,

HHS.
ACTION: Notice.
SUMMARY: In compliance with the

Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this

information collection are best assured
of having their full effect if received by
November 27, 2026.

E:\FR\FM\27OCN1.SGM

27OCN1

67593

Federal Register / Vol. 91, No. 206 / Tuesday, October 27, 2026 / Notices
FOR FURTHER INFORMATION CONTACT: To

obtain a copy of the data collection
plans and instruments, contact: Tom
Burklow, MD, Office of Clinical
Research Training and Medical
Education, NIH Clinical Center,
National Institutes of Health, 10 Center
Drive, Room 1N262, Bethesda, MD
20892–1158, or call non-toll-free
number 301–435–8015, or email your
request, including your address to:
[email protected]. Formal requests
for additional plans and instruments
must be requested in writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on August 6, 2026, page 50864
(Vol. 91, No. 450) and allowed 60 days
for public comment. No comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The Clinical Center, National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,

revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection Title:
Application Process for Clinical
Research Training and Medical
Education at the NIH Clinical Center
and Its impact on Course and Training
Program Enrollment and Effectiveness,
0925–0698, REVISION, Exp., date
October 31, 2026, National Institutes of
Health Clinical Center (CC), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The primary objective of the
application process is to allow the
Office of Clinical Research Training and
Medical Education (OCRTME) at the
NIH Clinical Center to evaluate

applicants’ qualifications to determine
applicants’ eligibility for training
programs managed by the Office.
Applicants must provide the required
information requested in the respective
applications to be considered a
candidate for participation. Information
submitted by candidates for training
programs is reviewed initially by
OCRTME administrative staff to
establish eligibility for participation.
Eligible candidates are then referred to
the designated training program
director/administrator or training
program selection committee for review
and decisions regarding acceptance for
participation. Upon acceptance,
OCRTME will collect required eligibility
documents for respective training
programs. A secondary objective of the
application process is to track
enrollment in training programs over
time.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours 400.

ESTIMATED ANNUALIZED BURDEN HOURS

Clinical Electives Program ..........................................

Pre Doctoral Students.
Physicians ..............
Pre Doctoral Students.
Physicians ..............
Pre Doctoral, PostDoctoral.
Pre Doctoral Students.

300

1

20/60

100

100
200

1
1

20/60
20/60

33
67

100
200

1
1

20/60
20/60

33
67

300

1

20/60

100

.................................

........................

1,200

........................

400

Resident Electives Program ........................................
Bioethics Fellowship Program .....................................
OCRTME Onboarding Application ..............................
Total .....................................................................

Dated: October 21, 2026.
Frederick D. Vorck Jr.,
Project Clearance Liaison, NIH Clinical
Center, National Institutes of Health.
[FR Doc. 2026–21904 Filed 10–26–26; 8:45 am]
BILLING CODE 4167–05–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health

lotter on DSK8BHNXB4PROD with NOTICES1

Average
burden per
response
(in hours)

Type of
respondents

Graduate Medical Education .......................................
Medical Research Scholars Program .........................

Government-Owned Inventions;
Availability for Licensing
AGENCY: National Institutes of Health,

HHS.
ACTION: Notice.
SUMMARY: The invention listed below is

owned by an agency of the U.S.

VerDate Sep<11>2014

17:59 Oct 26, 2026

Jkt 271001

Number of
respondents

Number of
responses
per
respondent

Form name

Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Inquiries related to this licensing
opportunity should be directed to:
Jonathan Motley at 240–669–5209, or
[email protected]. Licensing
information may be obtained by
communicating with the Technology
Transfer and Intellectual Property
Office, National Institute of Allergy and
Infectious Diseases, 5601 Fishers Lane,
Rockville, MD 20852; tel. 301–496–
2644. A signed Confidential Disclosure

PO 00000

Frm 00054

Fmt 4703

Sfmt 4703

Total annual
burden hours

Agreement will be required to receive
copies of unpublished information
related to the invention.
SUPPLEMENTARY INFORMATION:
Technology description follows:

Compositions and Methods for
Detecting Lymphatic Filariasis
Description of Technology
Lymphatic filariasis (elephantiasis;
LF) is a neglected tropical disease
characterized by painful deformation of
the host. LF affects over 120 million
people throughout the tropics and
subtropics of Asia, Africa, the Western
Pacific, and parts of the Caribbean and
South America. LF results from
infection with the filarial parasites
Wuchereria bancrofti or Brugia malayi.
Current methods of confirming active

E:\FR\FM\27OCN1.SGM

27OCN1